Portal de Periódicos da CAPES

FACTORS INVOLVED IN GROWTH‐INHIBITION OF MYCOPLASMA BY IMMUNE SERUM*

1967; Wiley; Volume: 143; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1967.tb27725.x

1749-6632

Stuart Riggs, John T. Sharp, Robert R. Carpenter,

Vector-borne infectious diseases

Annals of the New York Academy of SciencesVolume 143, Issue 1 p. 784-793 FACTORS INVOLVED IN GROWTH-INHIBITION OF MYCOPLASMA BY IMMUNE SERUM* Stuart Riggs, Stuart Riggs Baylor University, College of Medicine Department of Medicine Sections of Rheumatic and Infectious Diseases Houston, TexasSearch for more papers by this authorJohn T. Sharp, John T. Sharp Baylor University, College of Medicine Department of Medicine Sections of Rheumatic and Infectious Diseases Houston, TexasSearch for more papers by this authorRobert R. Carpenter, Robert R. Carpenter Baylor University, College of Medicine Department of Medicine Sections of Rheumatic and Infectious Diseases Houston, TexasSearch for more papers by this author Stuart Riggs, Stuart Riggs Baylor University, College of Medicine Department of Medicine Sections of Rheumatic and Infectious Diseases Houston, TexasSearch for more papers by this authorJohn T. Sharp, John T. Sharp Baylor University, College of Medicine Department of Medicine Sections of Rheumatic and Infectious Diseases Houston, TexasSearch for more papers by this authorRobert R. Carpenter, Robert R. Carpenter Baylor University, College of Medicine Department of Medicine Sections of Rheumatic and Infectious Diseases Houston, TexasSearch for more papers by this author First published: July 1967 https://doi.org/10.1111/j.1749-6632.1967.tb27725.xCitations: 12 * These studies were aided by grants from the U. S. Public Health Service AM 05222 and AM 06450 and the Houston Veterans Administration Hospital. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Edward, D. G. ff. & W. A. Fitzgerald. 1964. Inhibition of growth of pleuropneumonialike organisms by antibody. J. Path. Bact. 68: 23–30. 2 Gornall, A. G., C. J. Bardawill & M. M. David. 1949. Determination of serum proteins by means of biuret reaction. J. Biol. Chem. 177: 751. 3 Scheidegger, J. J. 1955. Une micro méthode de l'immunoelectrophoresis. Internat. Arch. Allerg. and Applied Immunol. 7: 103. 4 Uriel, J. 1964. Immunoelectrophoretic Analysis.: 30. P. Grabar & P. Burtin, Eds. Elsevier Co., New York . 5 Ouchterlony, O. 1962. Diffusion-in-gel methods for immunological analysis II. Progr. Allergy. 6: 30–154. 6 Fireman, P., W. E. Vannier & H. Goodman. 1964. Immunochemical studies of human serum fractionated by gel filtration with sephadex G-200. Proc. Soc. Exptl. Biol. Med. 115: 845–849. 7 Campbell, D. H., Garvey, J. S. & N. E. Cremer. 1963. Methods in Immunology. 57–62. W. A. Benjamin, Inc., New York . 8 Ishizaka, K., T. Ishizaka, E. H. Lee & H. H. Fudenberg. 1965. Immunochemical properties of human γA isohemagglutinin. I. Comparisons with γG- and γM-globulin antibodies. J. Immunol. 95: 197–208. 9 Riley, W. A., S. Riggs & J. T. Sharp. Unpublished data. 10 Riley, W. A., J. T. Sharp & S. Riggs. Nature of labile serum component(s) required in immune inhibition of mycoplasmas. Arthritis & Rheum. in Press. Citing Literature Volume143, Issue1Biology of the MycoplasmaJuly 1967Pages 784-793 ReferencesRelatedInformation